Future studies are certainly warranted to further define the molecular pathways by which LMO1 regulates TTK expression, and to further evaluate the clinical significance of LMO1 expression as a prognostic marker of neuroendocrine differentiation of lung cancers and patient survival in prospective studies. Here, TTK is linked to lung cancer.